Irinotecan is a topoisomerase I inhibitor, functioning as a prodrug converted to 7-ethyl-10-hydroxycamptothecin. It exhibits broad antitumor activity, especially against metastatic colorectal cancer, small cell lung cancer, and solid tumors, and enhances radiation therapy effectiveness.
Usually ships within 24 hours.